Shaanxi Aierfu Tissue Engineering

Shaanxi Aierfu Tissue Engineering is a pioneering Chinese biotechnology company focused on regenerative medicine and tissue engineering. Established in 2002 and later acquired by China Regenerative Medicine International (CRMI), the company is renowned for developing ActivSkin (Antifu), the first tissue-engineered skin product to receive regulatory approval from the China Food and Drug Administration (CFDA). Its core expertise lies in the development of skin substitutes and other tissue-engineered constructs for the treatment of severe burns, chronic wounds, and skin defects. The company operates as a key research and production base within the CRMI group, leveraging advanced cell culture and scaffold technologies to provide innovative solutions for wound care and tissue repair.